Laboratory Corporation of America Holdings (LH) Income Statement
An income statement shows a company's revenue, expenses, and profit over a reporting period.
Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments.
Total Revenue Chart for Laboratory Corporation of America Holdings
Laboratory Corporation of America Holdings (LH) revenue for FY2025 was USD 14.0B, a 7.2% change from FY2024. Laboratory Corporation of America Holdings's revenue grew from USD 313.9M in 1988 to USD 14.0B in 2025 (4344.6% over 37 years). Earnings per share grew from USD 1.38 in 2000 to USD 10.46 in 2025 (657.7%). Revenue compound annual growth rate: 5-year CAGR of -0.0%, 10-year CAGR of 4.9%, 20-year CAGR of 7.4%.
Total Revenue (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $29.89B
- Implied Share Price
- $368.16
- Enterprise Value
- $35.77B
- Revenue (TTM)
- $14.59B
- EBITDA
- $2.35B
- Profit Margin
- 6.88%
- Trailing P/E
- 30.18
- Forward P/E
- 18.66
- Price/Book (MRQ)
- 3.31
- Price/Sales (TTM)
- 2.05
- EV/EBITDA
- 16.53
- EV/Revenue
- 2.45
- Dividend Yield
- 0.80%
- Book Value
- $108.96
- Free Cash Flow (FY2025)
- $1.21B
- Free Cash Flow Yield
- 4.03%
Snapshot as of 30th October 2026 — not point-in-time controlled, may lag the live market by a few days.